AI in Healthcare: Developing a Targeted Strategy

1
AI in Healthcare Developing a Targeted
Strategy Our clients medication has long been a
staple in the U.S. market, widely known for its
efficacy in pain relief and cardiovascular
health. However, recent clinical research has
impacted the brands market perception, with
studies such as the A, B, and C trials examining
the broader health implications of medication
use, especially for cardiovascular health in
low-dose regimens. The findings from these
studies have prompted mixed responses from
healthcare professionals (HCPs) and patients,
affecting their inclination toward our clients
medication use in general. Our client has a
tactical advantage in navigating the complexities
of the medication industry due to its usage of
AI in healthcare to understand consumer and HCPs
attitudes and preferences.
Background The A trial reviewed medications
effect on preventing cardiovascular events in
diabetic patients but reported no significant
advantage in primary prevention, leading to
skepticism among HCPs. Similarly, the B trial,
our clients own research initiative, echoed
caution by evaluating medications limited
benefits in specific populations. Lastly, the C
trial funded by NIH found no substantial
improvement in life span with daily low-dose
medication use in older adults. Consequently,
this emerging data has shifted the perspectives
of HCPs and patients alike, influencing Our
clients market positioning. AI in Healthcare
The Approach to Market Strategy Considering the
shifting landscape, our client has recognized the
need for a refined approach to understand and
cater to HCP and patient sentiments. The proposed
strategy leverages AI in healthcare to segment
and analyze the attitudes of HCPs and patients
2

• toward Our clients medication, enabling targeted
  interventions. The primary goals of this AI-
  driven approach include identifying segments that
  have remained positive about Our clients
  medication, converting those who have become
  skeptical, and gaining a nuanced understanding
  of the motivational factors and distinct
  characteristics of each group.
• AI in Healthcare Key Findings and Data Analysis
• The analysis using AI in healthcare reveals
  distinct groups based on their sentiments and
  prescribing behaviors
• Decline in Positive Sentiment
• Many HCPs and patients who previously viewed our
  clients medication favorably are showing a
  shift towards neutral or negative perspectives
  due to concerns around medications
  effectiveness in primary prevention, as
  highlighted by recent studies.
• Patients are more sensitive to these findings
  than HCPs, showing a marked decline in
  positivity. This change is also influenced by
  factors such as cost and perceived benefits
  compared to generic medication alternatives.
• Comparison with Generic Medication
• Some patients and HCPs have increasingly opted
  for generic medication due to its affordability
  and similar efficacy profile. HCPs who remained
  positive about medication often expressed
  preferences for generics, citing cost-
  efficiency and consistent patient outcomes.
• Distinct Profiles of Positive vs. Negative
  Segments
• For those remaining positive toward our clients
  medication, preferences often stem from
  long-term usage and established patient-doctor
  trust. Many of these users appreciate our
  clients unique features, such as coated or
  enteric- coated options, which are perceived as
  gentler on the stomach.
• Negative perspectives are often found in
  individuals skeptical about medications primary
  prevention efficacy. Common reasons include the
  cost of branded medication and doubts over added
  benefits from Our clients coating or other
  features.
• These profiles show a trend where the perceived
  benefit of Our clients coating or branding may
  not justify the cost for many patients,
  particularly when generics are available at a
  lower price.
• Some additional findings are not disclosed due to
  the interest of confidentiality.
• Strategic Steps to Regain and Retain Positive
  Sentiment
• With insights derived from the data analysis
  using AI in healthcare, our clients approach to
  addressing HCP and patient perspectives can be
  tailored in specific ways to enhance engagement,
  improve brand loyalty, and educate the market on
  the unique benefits of Our clients medication
• 1. Segmented and Unbiased Targeting Using AI
• o By segmenting both HCPs and patients based on
  inclination, our client can better understand
  drivers of positivity and negativity. This
  approach will inform

3

• efforts to increase the base of loyal HCPs and
  patients while addressing the concerns of those
  who have turned skeptical.
• o For example, targeting the specific profiles
  that remained positive with tailored messaging
  around the benefits of Our clients formulations,
  such as enteric coating, may reinforce brand
  loyalty.
• Deep Dive Analysis for Insightful Messaging
• Each segments unique characteristicssuch as
  age, clinic size, fitness priorities, health
  concerns and media consumption inform tailored
  strategies for messaging. Younger HCPs and those
  operating in smaller clinics may have different
  informational needs than established doctors in
  larger facilities.
• Patients with health-conscious profiles, like
  those worried about fitness or who have a higher
  BMI, might benefit from educational content that
  clarifies the protective role of medication in
  specific contexts, alongside lifestyle
  recommendations that align with medication use.
• Educational Initiatives on Recent Research and
  Medication Use
• Addressing the confusion resulting from clinical
  trials such as A, B, and C, our client could
  develop educational content that clarifies when
  medication use is most beneficial, backed by
  clear, evidence-based explanations that speak to
  both HCPs and patients.
• Interactive webinars, seminars, and targeted
  digital campaigns can reinforce Our clients
  commitment to transparent communication and
  educate HCPs on the specific scenarios where
  medication can provide health benefits without
  undue risk.
• Emphasis on Unique Product Benefits
• While generics remain attractive for
  cost-conscious patients, our client can
  differentiate its product through an emphasis on
  features like enteric coating, known to reduce
  gastrointestinal side effects, which can be a
  persuasive point for patients and HCPs
  prioritizing gastrointestinal health.
• By aligning this messaging with targeted
  marketing toward individuals who may benefit
  from these product features, our client can
  reestablish the brands premium positioning,
  focusing on quality and patient-centered care.
• Strategize Better with AI in Healthcare
• The application of AI in healthcare to understand
  the sentiments and preferences of HCPs and
  patients provides our clients with a strategic
  advantage in navigating the complexities of the
  medication market. The study was conducted along
  with trials that were run to get a time
  advantage in driving actions faster than
  competitors. Through informed and nuanced AI-
  driven strategies, our client is positioned to
  reinforce its market presence, enhance brand
  loyalty, and sustain its role as a trusted
  provider of medication in the U.S .
• Contact us at GrapheneAI to enhance your market
  position with AI in healthcare. Also, read about
  the other case study where our client was able to
  regain and retain positive sentiment.